Immutep Ltd (PRRUF) Financials
PRRUF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 57.5 million | 15.0 million |
| March 31, 2026 | ? | ? |
| Dec. 31, 2025 | 98.3 million | 32.3 million |
| June 30, 2025 | 103.2 million | 8.8 million |
PRRUF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -18.5 million | ? |
| March 31, 2026 | 9.3 million | ? |
| Dec. 31, 2025 | -19.2 million | ? |
| June 30, 2025 | -11.0 million | 382581 |
PRRUF Net Income
No data available :(
PRRUF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 47.5 million | - | 522760 |
| March 31, 2026 | - | - | - |
| Dec. 31, 2025 | 66.2 million | - | 807681 |
| June 30, 2025 | 85.3 million | - | 342158 |
PRRUF Shares Outstanding
PRRUF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 191 | - | 33.4 million | - |
| March 31, 2026 | 3425 | - | - | - |
| Dec. 31, 2025 | 61861 | - | 34.0 million | - |
| June 30, 2025 | 11267 | 11.9 million | 1.5 million | - |
PRRUF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 7.2 million | 731412 |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | 2.7 million | 753475 |
| June 30, 2025 | 623451 | 11.9 million |
PRRUF
Price: $0.02
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 44.2 million